Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Gains from Investment Securities (2016 - 2025)

Ultralife has reported Gains from Investment Securities over the past 16 years, most recently at $967351.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $967351.0 for Q4 2025, up 269.9% from a year ago — trailing twelve months through Dec 2025 was $967351.0 (up 269.9% YoY), and the annual figure for FY2025 was $967351.0, up 269.9%.
  • Gains from Investment Securities for Q4 2025 was $967351.0 at Ultralife, down from $987097.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ULBI hit a ceiling of $1.2 million in Q2 2022 and a floor of -$3000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $425760.0 (2021), compared with a mean of $530048.8.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 99.68% in 2024 and later surged 28428.82% in 2025.
  • Ultralife's Gains from Investment Securities stood at $590000.0 in 2021, then skyrocketed by 103.74% to $1.2 million in 2022, then plummeted by 100.25% to -$3000.0 in 2023, then soared by 8817.33% to $261520.0 in 2024, then soared by 269.9% to $967351.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $967351.0 (Q4 2025), $987097.0 (Q3 2025), and $99005.0 (Q2 2025) per Business Quant data.